ASCO GUIDELINES Bundle

Potentially Curable Pancreatic Adenocarcinoma

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475498

Contents of this Issue

Navigation

Page 4 of 5

Recommendation 5.1 ➤ People with potentially curable pancreatic cancer should have a full assessment of symptom burden, psychological status, and social supports as early as possible, preferably at the first visit. In some cases, this may indicate a need for a formal palliative care consult and services. (Strong Recommendation; IC-B-I) Recommendation 5.2 ➤ People who have undergone pancreatectomy for potentially curable pancreatic cancer should receive ongoing supportive care for symptom burden that may result from the surgery and (preoperative and/or adjuvant) chemotherapy. (Strong Recommendation; IC-B-I) Recommendation 6.1 ➤ In the absence of RCT evidence, the Panel recommends that people who have completed treatment for potentially curable pancreatic cancer and have no evidence of disease be monitored for recovery of treatment-related toxicities and recurrence. Visits may be offered at 3- to 6- month intervals; the role of serial cross-sectional imaging, the extent to which surveillance intervals should be prolonged over time, and the duration of recommended surveillance are all undefined. (Moderate Recommendation; IC-B-L)

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Potentially Curable Pancreatic Adenocarcinoma